GlassScriptPhysician profile
Aabha Beri
NPI 1508207507
$467.89
in general payments reported to CMS, 2019-2025
15 companies · $87.82 in 2025
The $87.82 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.95 · 2020: $20.33 · 2022: $64.22 · 2023: $193 · 2024: $18.12 · 2025: $87.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $86.09 | 2019-2024 | Arexvy, Shingrix |
| Dexcom, INC. | $61.38 | 2023 | Dexcom G6 Transmitter |
| Abbott Laboratories | $47.48 | 2023-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $34.15 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $29.67 | 2019-2022 | |
| Inspire Medical Systems, INC. | $27.30 | 2023 | Inspire |
| Janssen Pharmaceuticals, INC | $25.24 | 2019 | |
| Amgen INC. | $24.59 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $22.13 | 2023 | Farxiga |
| Merck Sharp & Dohme LLC | $21.03 | 2022 | |
| Novo Nordisk INC | $20.65 | 2023 | |
| Alnylam Pharmaceuticals INC. | $20.35 | 2023 | Givlaari |
| Axsome Therapeutics, INC. | $17.84 | 2025 | Symbravo |
| Pfizer INC. | $15.74 | 2023 | |
| Philips North America LLC | $14.25 | 2025 | Amara Cushions |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aabha Beri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.